SavedAdd your journal

Journals / Türk Kardiyoloji Derneği Arşivi / 2021 / Cilt: 49 - Sayı: 8

The relationship between serum rheumatoid factor level and SYNTAX score I in patients with acute myocardial infarction

Akut miyokart enfarktüslü hastalarda serum romatoid faktör düzeyi ile SYNTAX skoru I arasındaki ilişki

Alaa Quisi
Gökhan Alıcı
Ömer Genç
İbrahim Halil Kurt
Taner Şeker
Huda Almadhoun
Pages
666–674
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the NSTEMI group, RF levels were significantly higher in the SSI >22 group than that in the SSI ≤22 group (15.5 IU/mL [8.0-69.5 IU/mL] ver- sus 13.0 IU/mL [4.0-36.0 IU/mL, respectively], p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Rheumatoid factor (RF) has been associated with an increased likelihood of developing coronary artery dis - ease and cardiovascular mortality.
📊
Key Findings & Data:Methods: This study included 418 consecutive patients who were diagnosed with acute myocardial infarction and underwent coronary angiography.
💡
Conclusion & Impact:In the NSTEMI group, RF levels were significantly higher in the SSI >22 group than that in the SSI ≤22 group (15.5 IU/mL [8.0-69.5 IU/mL] ver- sus 13.0 IU/mL [4.0-36.0 IU/mL, respectively], p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Rheumatoid factor (RF) has been associated with an increased likelihood of developing coronary artery dis - ease and cardiovascular mortality. This study aimed to eval- uate the relationship between serum RF levels and SYNTAX score I (SSI) in patients with acute myocardial infarction. Methods: This study included 418 consecutive patients who were diagnosed with acute myocardial infarction and underwent coronary angiography. The baseline serum RF levels of all patients were measured. The study population was divided into 2 groups, namely, ST-segment elevation myocardial infarction (STEMI) group (218 patients) and non-ST-segment elevation myocardial infarction (NSTEMI) group (200 patients). Each group was further divided into 2 subgroups, namely, SSI ≤22 group and SSI >22 group. Results: In the STEMI group, RF levels were significantly higher in the SSI >22 group than that in the SSI ≤22 group (13.0 IU/mL [7.0-51.0 IU/mL] versus 11.0 IU/mL [4.0-37.0 IU/mL], respectively, p=0.002). In the NSTEMI group, RF levels were significantly higher in the SSI >22 group than that in the SSI ≤22 group (15.5 IU/mL [8.0-69.5 IU/mL] ver- sus 13.0 IU/mL [4.0-36.0 IU/mL, respectively], p

Özet

Amaç: Romatoid faktör (RF), artmış koroner arter hastalığı ve kardiyovasküler mortalite ile ilişkilendirilmiştir. Bu çalış- manın amacı, akut miyokart enfarktüslü hastalarda serum RF düzeyleri ile SYNTAX skoru I (SSI) arasındaki ilişkiyi değerlendirmektir. Yöntemler: Bu çalışmaya akut miyokart enfarktüsü tanısı alan ve koroner anjiyografi yapılmış ardışık 418 hasta alın- dı. Tüm hastaların bazal serum RF seviyeleri ölçüldü. Ça- lışma popülasyonu iki gruba ayrıldı; ST segment yükselmeli miyokart enfarktüsü (STEMI) grubu (n=218) ve ST segment yükselmesiz miyokart enfarktüsü (NSTEMI) grubu (n=200). Daha sonra her grup SSI’e göre iki alt gruba ayrıldı; SSI ≤22 grup ve SSI >22 grup. Bulgular: STEMI grubunda, RF düzeyleri SSI> 22 grubun- da SSI ≤22 grubuna göre anlamlı olarak yüksekti (13.0 IU / mL [7.0-51.0 IU / mL] vs. 11.0 IU / mL [4.0-37.0 IU / mL], sırasıyla, p = 0.002). NSTEMI grubunda, RF düzeyleri SSI> 22 grubunda SSI ≤22 grubuna göre anlamlı olarak yüksekti (15.5 IU / mL [8.0-69.5 IU / mL] vs. 13.0 IU / mL [4.0-36.0 IU / mL], sırasıyla, p

🔖

Cite This Article

Quisi, A., Alıcı, G., Genç, Ö., Kurt, İ. H., Şeker, T., Almadhoun, H. (2022). The relationship between serum rheumatoid factor level and SYNTAX score I in patients with acute myocardial infarction. Türk Kardiyoloji Derneği Arşivi, Cilt: 49 - Sayı: 8, 666–674. https://ajindex.com/articles/632362

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 2012
  2. [Crossref] 2. Sanjadi M, Rezvanie Sichanie Z, Totonchi H, Karami J, Re- zaei R, Aslani S. Atherosclerosis and autoimmunity: a growing relationship. Int J Rheum Dis 2018
  3. [Crossref] 3. Sherer Y, Shoenfeld Y. Atherosclerosis. Ann Rheum Dis 2002
  4. [Crossref] 4. Grainger DJ, Bethell HW. High titres of serum antinucle- ar antibodies, mostly directed against nucleolar antigens, are associated with the presence of coronary atherosclero- sis. Ann Rheum Dis 2002
  5. [Crossref]https://doi. org/10.1136/ard.61.2.110 5. Edwards CJ, Syddall H, Goswami R, Goswami P, Dennison EM, Arden NK, et al. The autoantibody rheumatoid factor may be an independent risk factor for ischaemic heart dis- ease in men. Heart 2007
  6. [Crossref] 6. Hannawi S, Hannawi H, Alokaily F, Naredo E, Moller I, Al Salmi I. Recent-onset of rheumatoid arthritis leads to in- crease in wall thickness of left anterior descending coronary artery. An evidence of subclinical coronary artery disease. Saudi Med J 2018
  7. [Crossref] 7. El Bakry SA, Fayez D, Morad CS, Abdel-Salam AM, Ab- del-Salam Z, ElKabarity RH, et al. Ischemic heart disease and rheumatoid arthritis: Do inflammatory cytokines have a role? Cytokine 2017
  8. [Crossref] 8. Alizade E, Avci A, Acar G, Fidan S, Ocal L, Bulut M, et al. The relationship between rheumatoid factor levels and cor- onary artery lesion complexity and severity in patients with stable coronary artery disease. Postepy Kardiol Interwency- jnej 2015
  9. [Crossref] 9. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2018
  10. [Crossref] 10. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, An- dreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without per- sistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016
  11. [Crossref] 11. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikk